Prolactin signaling via Janus kinase-signal transducer and activator of transcription (JAK-STAT) is shown to promote tumor growth [52] and the Hippo pathway regulates metabolic reprogramming to promote the growth of malignant tumors [53]. This evidence concerns the gene PRL and cancer.